These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 28053143)
1. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling. Matsumoto S; Fujii S; Kikuchi A J Biochem; 2017 Jan; 161(1):27-35. PubMed ID: 28053143 [TBL] [Abstract][Full Text] [Related]
2. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target. Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma. Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592 [TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic significance of Arl4c expression in colorectal cancer. Chen X; Su Z; Wang S; Xu H Cancer Biomark; 2016; 16(2):253-7. PubMed ID: 26756615 [TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signalling in adrenal physiology and tumour development. Berthon A; Martinez A; Bertherat J; Val P Mol Cell Endocrinol; 2012 Mar; 351(1):87-95. PubMed ID: 21930188 [TBL] [Abstract][Full Text] [Related]
7. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms. Fu X; Li L; Peng Y J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046 [TBL] [Abstract][Full Text] [Related]
8. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301 [TBL] [Abstract][Full Text] [Related]
10. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target. Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985 [TBL] [Abstract][Full Text] [Related]
11. ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer. Kanai R; Uehara T; Yoshizawa T; Kamakura M; Nakajima T; Kinugawa Y; Iwaya M; Asaka S; Kitazawa M; Nagaya T; Ota H BMC Cancer; 2023 May; 23(1):478. PubMed ID: 37237373 [TBL] [Abstract][Full Text] [Related]
12. The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis. Fujii S; Kiyoshima T Pathol Int; 2023 Jun; 73(6):217-233. PubMed ID: 37098842 [TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140 [TBL] [Abstract][Full Text] [Related]
14. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180 [TBL] [Abstract][Full Text] [Related]
15. ADP-ribosylation factors 1 and 6 regulate Wnt/β-catenin signaling via control of LRP6 phosphorylation. Kim W; Kim SY; Kim T; Kim M; Bae DJ; Choi HI; Kim IS; Jho E Oncogene; 2013 Jul; 32(28):3390-6. PubMed ID: 22907437 [TBL] [Abstract][Full Text] [Related]
16. Re: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. Cristóbal I; Rincón R; Manso R; Rojo F; García-Foncillas J J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25136032 [No Abstract] [Full Text] [Related]
17. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation. Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755 [TBL] [Abstract][Full Text] [Related]
18. A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures. Matsumoto S; Fujii S; Sato A; Ibuka S; Kagawa Y; Ishii M; Kikuchi A EMBO J; 2014 Apr; 33(7):702-18. PubMed ID: 24562386 [TBL] [Abstract][Full Text] [Related]
19. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability. Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084 [TBL] [Abstract][Full Text] [Related]
20. KRAS and cancer stem cells in APC-mutant colorectal cancer. Fearon ER; Wicha MS J Natl Cancer Inst; 2014 Feb; 106(2):djt444. PubMed ID: 24491303 [No Abstract] [Full Text] [Related] [Next] [New Search]